Tien Liang BioTech Co., Ltd. (TPEX:4127)
Taiwan · Delayed Price · Currency is TWD 67.10
-4.10 (-5.76%)
Jun 18, 2026, 1:30 PM CST
Tien Liang BioTech Market Cap
Tien Liang BioTech has a market cap or net worth of 3.07 billion as of June 18, 2026. Its market cap has increased by 79.41% in one year.
Market Cap
3.07B
Enterprise Value
3.50B
Revenue
593.46M
Ranking
n/a
PE Ratio
483.92
Stock Price
67.10
Market Cap Chart
Since July 19, 2005, Tien Liang BioTech's market cap has increased from 767.70M to 3.07B, an increase of 299.96%. That is a compound annual growth rate of 6.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 3.07B | 116.45% |
| Dec 31, 2025 | 1.42B | -25.30% |
| Dec 31, 2024 | 1.90B | 186.21% |
| Dec 29, 2023 | 663.52M | -6.15% |
| Dec 30, 2022 | 706.99M | 4.39% |
| Dec 30, 2021 | 677.25M | 32.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LIWANLI Innovation | 5.47B |
| SCI Pharmtech | 5.18B |
| Orient EuroPharma | 3.90B |
| Easywell Biomedicals | 3.83B |
| Yoda Pharmaceuticals | 3.27B |
| Maywufa Company | 2.90B |
| Merdury Biopharmaceutical | 2.74B |
| Allied Biotech | 2.59B |